• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $EYE

    National Vision Holdings Inc.

    Subscribe to $EYE
    $EYE
    Ophthalmic Goods
    Health Care

    National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. As of January 2, 2021, the company operated through 1,205 retail stores, as well as various e-commerce websites. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.

    IPO Year: 2017

    Exchange: NASDAQ

    Website: nationalvision.com

    Recent Analyst Ratings for National Vision Holdings Inc.

    DatePrice TargetRatingAnalyst
    5/9/2025$21.00Neutral → Buy
    Citigroup
    5/7/2025Underperform → Buy
    BofA Securities
    10/17/2023$25.00 → $16.00Buy → Neutral
    Goldman
    7/27/2023$28.00 → $22.00Buy → Neutral
    Citigroup
    7/27/2023$30.00 → $21.00Overweight → Equal Weight
    Wells Fargo
    5/2/2023Overweight → Equal Weight
    Barclays
    3/31/2023$23.00Hold → Buy
    Loop Capital
    1/17/2023Overweight → Equal-Weight
    Morgan Stanley
    11/7/2022$40.00 → $45.00Buy
    Jefferies
    6/27/2022$31.00 → $32.00Neutral → Buy
    Goldman
    See more ratings

    National Vision Holdings Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Peeler D Randolph bought $264,200 worth of shares (25,000 units at $10.57) (SEC Form 4)

      4 - National Vision Holdings, Inc. (0001710155) (Issuer)

      8/14/24 4:27:52 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • Director Hepner Virginia A bought $10,365 worth of shares (1,000 units at $10.37), increasing direct ownership by 3% to 36,635 units (SEC Form 4)

      4 - National Vision Holdings, Inc. (0001710155) (Issuer)

      8/14/24 4:26:51 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • Fahs L Reade bought $299,200 worth of shares (20,000 units at $14.96), increasing direct ownership by 3% to 633,097 units (SEC Form 4)

      4 - National Vision Holdings, Inc. (0001710155) (Issuer)

      5/14/24 8:01:46 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • Peeler D Randolph bought $491,198 worth of shares (34,000 units at $14.45) (SEC Form 4)

      4 - National Vision Holdings, Inc. (0001710155) (Issuer)

      5/14/24 8:00:26 AM ET
      $EYE
      Ophthalmic Goods
      Health Care

    National Vision Holdings Inc. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • National Vision Holdings, Inc. Reports First Quarter 2025 Financial Results

      Successful Execution of New Transformation Initiatives and Cost Reduction Actions Delivered Strong First Quarter First quarter 2025 highlights compared to Q1 2024: Net revenue from continuing operations of $510.3 million, an increase of 5.7% Comparable store sales growth of 4.1% and Adjusted Comparable Store Sales Growth of 5.5% represented the 9th consecutive quarter of positive growth Income from continuing operations of $14.2 million, Diluted EPS from continuing operations of $0.18 Adjusted Operating Income from continuing operations of $41.3 million Adjusted Diluted EPS from continuing operations of $0.34 Raises fiscal 2025 outlook National Vision Holdings, Inc. (NASDAQ:E

      5/7/25 6:00:00 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Appoints Alex Wilkes as CEO

      Reade Fahs to Assume Executive Chairman Position Transition Effective August 1, 2025 National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") today announced that its Board of Directors has appointed Alex Wilkes as the Company's next Chief Executive Officer, effective August 1, 2025, and he will join the Company's Board at that time. Mr. Wilkes succeeds Reade Fahs who will assume the role of Executive Chairman of the Board. Mr. Fahs will continue to work closely with Mr. Wilkes, ensuring a smooth transition. "National Vision has been on a journey of significant transformation for the past few years, and today I am pleased to announce the next chapter in that tran

      4/29/25 6:00:00 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Holdings, Inc. Announces First Quarter 2025 Earnings Release and Conference Call

      National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") will report its first quarter 2025 financial results before the market opens on Wednesday, May 7, 2025, and will host a conference call at 8:30 a.m. Eastern Time. To pre-register for the conference call and obtain a dial-in number and passcode, please refer to the "Investors" section of the Company's website at www.nationalvision.com/investors. A live audio webcast of the conference call, together with related materials, will be available online in the "Investors" section of the Company's website. A replay of the audio webcast will be available shortly after the broadcast. About National Vision Holdings, Inc.

      4/24/25 8:00:00 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Names VML Agency of Record

      Agency to Lead Creative Brand Transformation for Brands Including America's Best and Eyeglass World National Vision Holdings, Inc., a leading optical retail company behind brands like America's Best and Eyeglass World, has appointed VML as its agency of record (AOR) following a competitive review. VML will play a key role in leading National Vision's brand evolution, redefining National Vision's communication and brand platforms with a focus on creative, CRM, social strategy, brand identity and design, and experiential. The new partnership will support National Vision's continued transformation for long term success by driving connection with new and current audiences, while reinforcing it

      3/26/25 9:28:00 AM ET
      $EYE
      $WPP
      Ophthalmic Goods
      Health Care
      Advertising
      Consumer Discretionary
    • National Vision Appoints Jim McGrann and Michael Nicholson to Board of Directors

      Enters into Cooperation Agreement with Engine Capital National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") today announced the appointment of two new independent directors, Jim McGrann and Michael Nicholson to its Board of Directors (the "Board"), effective March 17, 2025. Mr. McGrann will serve on the Board's Compensation Committee and Mr. Nicholson will serve on the Board's Audit Committee and Nominating and Corporate Governance Committee. With the addition of Messrs. McGrann and Nicholson, the Board will expand from 9 to 11 members. The Board has also formed an Advisory Committee that will help oversee National Vision's ongoing transformation initiatives with

      3/17/25 4:05:00 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Announces Participation in UBS Global Consumer and Retail Conference

      National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") today announced that the Company is scheduled to present at the UBS Global Consumer and Retail Conference on Wednesday, March 12, 2025, at 2:00 p.m. Eastern Time. A live webcast of the presentation can be accessed in the "Investors" section of the Company's website at www.nationalvision.com/investors. The webcast will be archived and available on the website shortly after the event. About National Vision Holdings, Inc. National Vision Holdings, Inc. (NASDAQ:EYE) is one of the largest optical retail companies in the United States with over 1,200 stores in 38 states and Puerto Rico. With a mission of helping p

      3/11/25 8:00:00 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Holdings, Inc. Reports Fourth Quarter and Fiscal 2024 Financial Results

      Strong Fourth Quarter Results Reflect Successful Execution on Store-Level Transformation Initiatives Introduced Targeted Initiatives to Broaden Appeal and Expand Customer Base Actions Taken to Reduce Costs and Strengthen Profitability Fourth quarter 2024 highlights: Net revenue from continuing operations of $437.3 million, an increase of 3.9% as compared to Q4 2023 Comparable store sales growth of 2.6% and Adjusted Comparable Store Sales Growth of 1.5% as compared to Q4 2023 Net loss from continuing operations of $(29.4) million, Diluted EPS from continuing operations of $(0.37) Adjusted Operating Income from continuing operations increased to $3.2 million from $(2.7) mill

      2/26/25 6:00:00 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Appoints Christopher Laden as Chief Financial Officer

      National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") today announced the appointment of Christopher Laden as Chief Financial Officer, effective March 31, 2025. He will succeed Melissa Rasmussen who, as previously announced, will step down from the Company, effective March 3, 2025. "We are thrilled to welcome Chris to National Vision. He has a proven track record of successfully developing finance organizations into strong cross-functional business partners by focusing on accountability, employee development, and driving efficiencies through the use of digitization. His experience in both the service and optical industries will be instrumental as we move forward

      2/26/25 5:59:00 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Holdings, Inc. Announces Fourth Quarter and Fiscal 2024 Earnings Release and Conference Call

      National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") will report its fourth quarter and fiscal 2024 financial results before the market opens on February 26, 2025 and will host a conference call at 8:00 a.m. Eastern Time. To pre-register for the conference call and obtain a dial-in number and passcode, please refer to the "Investors" section of the Company's website at www.nationalvision.com/investors. A live audio webcast of the conference call, together with related materials, will be available online in the "Investors" section of the Company's website. A replay of the audio webcast will be available shortly after the broadcast. About National Vision Holdin

      2/12/25 8:00:00 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • Mueller Water Products Appoints Melissa Rasmussen as Chief Financial Officer

      ATLANTA, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Mueller Water Products, Inc. (NYSE:MWA), a leading manufacturer and marketer of products and services used in the transmission, distribution and measurement of water in North America, announced that it has named Melissa Rasmussen as its Senior Vice President and Chief Financial Officer (CFO) effective March 4, 2025 following a comprehensive search with the support of a leading executive search firm. Ms. Rasmussen is a seasoned financial executive with more than 25 years of experience, most recently serving as the CFO of National Vision, Inc. (NASDAQ:EYE). Ms. Rasmussen joined National Vision in 2019 as the Chief Accounting Officer prior to her pr

      1/16/25 4:09:55 PM ET
      $EYE
      $MWA
      Ophthalmic Goods
      Health Care
      Metal Fabrications
      Industrials

    National Vision Holdings Inc. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by National Vision Holdings Inc.

      SC 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

      11/14/24 12:33:08 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • Amendment: SEC Form SC 13G/A filed by National Vision Holdings Inc.

      SC 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

      11/12/24 4:45:48 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • Amendment: SEC Form SC 13G/A filed by National Vision Holdings Inc.

      SC 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

      11/4/24 1:18:26 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • Amendment: SEC Form SC 13G/A filed by National Vision Holdings Inc.

      SC 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

      9/9/24 11:06:17 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • SEC Form SC 13G filed by National Vision Holdings Inc.

      SC 13G - National Vision Holdings, Inc. (0001710155) (Subject)

      2/14/24 3:36:06 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • SEC Form SC 13G/A filed by National Vision Holdings Inc. (Amendment)

      SC 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

      2/14/24 3:08:01 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • SEC Form SC 13G/A filed by National Vision Holdings Inc. (Amendment)

      SC 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

      2/13/24 5:09:41 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • SEC Form SC 13G/A filed by National Vision Holdings Inc. (Amendment)

      SC 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

      2/12/24 6:50:25 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • SEC Form SC 13G/A filed by National Vision Holdings Inc. (Amendment)

      SC 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

      2/9/24 3:47:48 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • SEC Form SC 13G/A filed by National Vision Holdings Inc. (Amendment)

      SC 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

      2/9/24 9:28:33 AM ET
      $EYE
      Ophthalmic Goods
      Health Care

    National Vision Holdings Inc. SEC Filings

    See more
    • SEC Form 10-Q filed by National Vision Holdings Inc.

      10-Q - National Vision Holdings, Inc. (0001710155) (Filer)

      5/8/25 8:36:28 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - National Vision Holdings, Inc. (0001710155) (Filer)

      5/7/25 6:05:18 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • SEC Form DEF 14A filed by National Vision Holdings Inc.

      DEF 14A - National Vision Holdings, Inc. (0001710155) (Filer)

      4/29/25 6:22:58 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - National Vision Holdings, Inc. (0001710155) (Filer)

      4/29/25 6:05:32 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by National Vision Holdings Inc.

      SCHEDULE 13G/A - National Vision Holdings, Inc. (0001710155) (Subject)

      4/28/25 7:50:53 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - National Vision Holdings, Inc. (0001710155) (Filer)

      3/17/25 5:00:37 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • SEC Form 10-K filed by National Vision Holdings Inc.

      10-K - National Vision Holdings, Inc. (0001710155) (Filer)

      2/26/25 6:09:10 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - National Vision Holdings, Inc. (0001710155) (Filer)

      2/26/25 6:03:14 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • SEC Form SCHEDULE 13G filed by National Vision Holdings Inc.

      SCHEDULE 13G - National Vision Holdings, Inc. (0001710155) (Subject)

      2/13/25 4:00:04 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - National Vision Holdings, Inc. (0001710155) (Filer)

      1/16/25 4:10:47 PM ET
      $EYE
      Ophthalmic Goods
      Health Care

    National Vision Holdings Inc. Leadership Updates

    Live Leadership Updates

    See more
    • National Vision Appoints Alex Wilkes as CEO

      Reade Fahs to Assume Executive Chairman Position Transition Effective August 1, 2025 National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") today announced that its Board of Directors has appointed Alex Wilkes as the Company's next Chief Executive Officer, effective August 1, 2025, and he will join the Company's Board at that time. Mr. Wilkes succeeds Reade Fahs who will assume the role of Executive Chairman of the Board. Mr. Fahs will continue to work closely with Mr. Wilkes, ensuring a smooth transition. "National Vision has been on a journey of significant transformation for the past few years, and today I am pleased to announce the next chapter in that tran

      4/29/25 6:00:00 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Appoints Jim McGrann and Michael Nicholson to Board of Directors

      Enters into Cooperation Agreement with Engine Capital National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") today announced the appointment of two new independent directors, Jim McGrann and Michael Nicholson to its Board of Directors (the "Board"), effective March 17, 2025. Mr. McGrann will serve on the Board's Compensation Committee and Mr. Nicholson will serve on the Board's Audit Committee and Nominating and Corporate Governance Committee. With the addition of Messrs. McGrann and Nicholson, the Board will expand from 9 to 11 members. The Board has also formed an Advisory Committee that will help oversee National Vision's ongoing transformation initiatives with

      3/17/25 4:05:00 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Appoints Christopher Laden as Chief Financial Officer

      National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") today announced the appointment of Christopher Laden as Chief Financial Officer, effective March 31, 2025. He will succeed Melissa Rasmussen who, as previously announced, will step down from the Company, effective March 3, 2025. "We are thrilled to welcome Chris to National Vision. He has a proven track record of successfully developing finance organizations into strong cross-functional business partners by focusing on accountability, employee development, and driving efficiencies through the use of digitization. His experience in both the service and optical industries will be instrumental as we move forward

      2/26/25 5:59:00 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • Mueller Water Products Appoints Melissa Rasmussen as Chief Financial Officer

      ATLANTA, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Mueller Water Products, Inc. (NYSE:MWA), a leading manufacturer and marketer of products and services used in the transmission, distribution and measurement of water in North America, announced that it has named Melissa Rasmussen as its Senior Vice President and Chief Financial Officer (CFO) effective March 4, 2025 following a comprehensive search with the support of a leading executive search firm. Ms. Rasmussen is a seasoned financial executive with more than 25 years of experience, most recently serving as the CFO of National Vision, Inc. (NASDAQ:EYE). Ms. Rasmussen joined National Vision in 2019 as the Chief Accounting Officer prior to her pr

      1/16/25 4:09:55 PM ET
      $EYE
      $MWA
      Ophthalmic Goods
      Health Care
      Metal Fabrications
      Industrials
    • National Vision Announces the Appointment of Alex Wilkes as President

      Patrick Moore to Retire as Chief Operating Officer National Vision Holdings, Inc. (NASDAQ:EYE) today announced the appointment of Alex Wilkes as National Vision's President, reporting to Reade Fahs, Chief Executive Officer of National Vision, effective August 19, 2024. This follows the Company's announcement on July 1, 2024 of Mark Banner joining the Company as Chief Stores Officer. Wilkes joins National Vision from CooperVision, a global leader in contact lenses, where he served as President of the Americas. Prior to CooperVision, Wilkes spent over a decade at EssilorLuxottica, a leading global eyewear company, in various roles including as Senior Vice President and General Manager of

      8/7/24 6:00:00 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Appoints Caitlin Zulla to Board of Directors

      Adds Healthcare and Financial Expertise to Board National Vision Holdings, Inc. (NASDAQ:EYE), one of the nation's largest optical retailers providing quality, affordable eye care and eyewear, announced today the appointment of Caitlin Zulla to its Board of Directors, effective immediately. Zulla will serve on the Board's Compensation Committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240801515969/en/(Photo: Business Wire) Zulla brings an extensive healthcare background, with expertise in primary care and specialty care services. She currently serves as Chief Executive Officer of Optum Health East, part of UnitedHealth G

      8/1/24 4:30:00 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Welcomes Mark Banner as New Chief Stores Officer

      National Vision Holdings, Inc. (NASDAQ:EYE) is pleased to announce the appointment of Mark Banner as the company's new Chief Stores Officer, effective July 8, 2024. Banner is a mission-driven specialty retailer who joins the company after a distinguished seven-year tenure at Sleep Number. Most recently, he served as senior vice president of retail and real estate. His extensive experience encompasses leading teams in sales, sales operations, digital, promotion and real estate. Before Sleep Number, Banner dedicated 18 years to Signet Jewelers, the world's largest specialty retailer jeweler. He began his career at Signet as a store manager and rose through the ranks to district manager, v

      7/1/24 4:15:00 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Puts Pediatric Eye Care in Focus for 2023-2024 Scholarship Program

      $7,500 to be Awarded to Third- and Fourth-Year Optometry Students in Program's Ninth Year National Vision, Inc., the nation's second largest optical retailer providing quality, affordable eye care and eyewear, announced today that its annual scholarship program is open for entries, providing eligible optometry students with a chance to win up to $7,500. This year's scholarship program challenges students to share their perspective on "Increasing Access to Eye Care for Children." Third- and fourth-year optometry students may submit written or video essays on the topic, offering their take on why proper vision care is important for all children. Entrants are also challenged to address how

      10/19/23 8:30:00 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Appoints New Chief Marketing Officer

      Joe VanDette Brings Two Decades of Transformative Marketing Experience to the Company National Vision Holdings, Inc. (NASDAQ:EYE), announced today that Joe VanDette has joined the company as Chief Marketing Officer, reporting to Chief Executive Officer Reade Fahs. VanDette will be responsible for leading the organization's Marketing function including strategic brand management, CRM, advertising and media, digital marketing, e-commerce and research/insights. "Joe is a talented individual with an impressive track record of using data driven customer-centric approaches to drive business expansion," said Reade Fahs, Chief Executive Officer of National Vision. "We expect he will fit in well w

      4/11/22 8:00:00 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Appoints Jose Armario to Board of Directors

      DULUTH, Ga.--(BUSINESS WIRE)--National Vision Holdings, Inc. (NASDAQ: EYE), one of the nation’s largest optical retailers providing quality, affordable eye care and eyewear, today announced the appointment of Jose Armario, chief executive officer and president at Bojangles’, Inc., to its Board of Directors, effective today. Armario will serve on the Board’s Nominating and Corporate Governance Committee. Following Armario’s appointment, National Vision’s Board consists of nine Directors, reflecting a gender balance among the eight independent members of the Board. “I’ve known Jose since the early ’90s when we both worked in optics before his success with McDonald’s and Bojangles,”

      2/4/21 4:30:00 PM ET
      $EYE
      Ophthalmic Goods
      Health Care

    National Vision Holdings Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • National Vision upgraded by Citigroup with a new price target

      Citigroup upgraded National Vision from Neutral to Buy and set a new price target of $21.00

      5/9/25 8:39:42 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision upgraded by BofA Securities

      BofA Securities upgraded National Vision from Underperform to Buy

      5/7/25 2:46:43 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision downgraded by Goldman with a new price target

      Goldman downgraded National Vision from Buy to Neutral and set a new price target of $16.00 from $25.00 previously

      10/17/23 7:19:16 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision downgraded by Citigroup with a new price target

      Citigroup downgraded National Vision from Buy to Neutral and set a new price target of $22.00 from $28.00 previously

      7/27/23 8:59:58 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision downgraded by Wells Fargo with a new price target

      Wells Fargo downgraded National Vision from Overweight to Equal Weight and set a new price target of $21.00 from $30.00 previously

      7/27/23 6:12:47 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision downgraded by Barclays

      Barclays downgraded National Vision from Overweight to Equal Weight

      5/2/23 8:57:10 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision upgraded by Loop Capital with a new price target

      Loop Capital upgraded National Vision from Hold to Buy and set a new price target of $23.00

      3/31/23 8:58:26 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision downgraded by Morgan Stanley

      Morgan Stanley downgraded National Vision from Overweight to Equal-Weight

      1/17/23 7:58:03 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • Jefferies resumed coverage on National Vision with a new price target

      Jefferies resumed coverage of National Vision with a rating of Buy and set a new price target of $45.00 from $40.00 previously

      11/7/22 9:14:37 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision upgraded by Goldman with a new price target

      Goldman upgraded National Vision from Neutral to Buy and set a new price target of $32.00 from $31.00 previously

      6/27/22 7:44:57 AM ET
      $EYE
      Ophthalmic Goods
      Health Care

    National Vision Holdings Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Legal & Strategy Officer Brandman Jared converted options into 1,889 shares and covered exercise/tax liability with 562 shares, increasing direct ownership by 3% to 44,705 units (SEC Form 4)

      4 - National Vision Holdings, Inc. (0001710155) (Issuer)

      4/30/25 4:27:11 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • Chief Brand & Mktg Officer Vandette Joseph converted options into 1,831 shares and covered exercise/tax liability with 545 shares, increasing direct ownership by 9% to 15,940 units (SEC Form 4)

      4 - National Vision Holdings, Inc. (0001710155) (Issuer)

      4/14/25 4:43:08 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • SEC Form 4 filed by Chief Financial Officer Laden Christopher

      4 - National Vision Holdings, Inc. (0001710155) (Issuer)

      4/1/25 4:17:22 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • SEC Form 3 filed by new insider Laden Christopher

      3 - National Vision Holdings, Inc. (0001710155) (Issuer)

      4/1/25 4:15:52 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • Director Nicholson Michael J was granted 3,327 units of Restricted Stock Units (SEC Form 4)

      4 - National Vision Holdings, Inc. (0001710155) (Issuer)

      3/24/25 4:35:11 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • SEC Form 3 filed by new insider Nicholson Michael J

      3 - National Vision Holdings, Inc. (0001710155) (Issuer)

      3/24/25 4:33:14 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • Director Mcgrann James M. was granted 3,327 units of Restricted Stock Units (SEC Form 4)

      4 - National Vision Holdings, Inc. (0001710155) (Issuer)

      3/24/25 4:32:14 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • SEC Form 3 filed by new insider Mcgrann James M.

      3 - National Vision Holdings, Inc. (0001710155) (Issuer)

      3/24/25 4:30:29 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • SEC Form 4 filed by SVP, CHIEF MERCH. & MC OFFICER Molony Megan

      4 - National Vision Holdings, Inc. (0001710155) (Issuer)

      3/10/25 4:39:13 PM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • SEC Form 4 filed by General Manager Patel Priti V

      4 - National Vision Holdings, Inc. (0001710155) (Issuer)

      3/10/25 4:37:54 PM ET
      $EYE
      Ophthalmic Goods
      Health Care

    National Vision Holdings Inc. Financials

    Live finance-specific insights

    See more
    • National Vision Holdings, Inc. Reports First Quarter 2025 Financial Results

      Successful Execution of New Transformation Initiatives and Cost Reduction Actions Delivered Strong First Quarter First quarter 2025 highlights compared to Q1 2024: Net revenue from continuing operations of $510.3 million, an increase of 5.7% Comparable store sales growth of 4.1% and Adjusted Comparable Store Sales Growth of 5.5% represented the 9th consecutive quarter of positive growth Income from continuing operations of $14.2 million, Diluted EPS from continuing operations of $0.18 Adjusted Operating Income from continuing operations of $41.3 million Adjusted Diluted EPS from continuing operations of $0.34 Raises fiscal 2025 outlook National Vision Holdings, Inc. (NASDAQ:E

      5/7/25 6:00:00 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Holdings, Inc. Announces First Quarter 2025 Earnings Release and Conference Call

      National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") will report its first quarter 2025 financial results before the market opens on Wednesday, May 7, 2025, and will host a conference call at 8:30 a.m. Eastern Time. To pre-register for the conference call and obtain a dial-in number and passcode, please refer to the "Investors" section of the Company's website at www.nationalvision.com/investors. A live audio webcast of the conference call, together with related materials, will be available online in the "Investors" section of the Company's website. A replay of the audio webcast will be available shortly after the broadcast. About National Vision Holdings, Inc.

      4/24/25 8:00:00 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Holdings, Inc. Reports Fourth Quarter and Fiscal 2024 Financial Results

      Strong Fourth Quarter Results Reflect Successful Execution on Store-Level Transformation Initiatives Introduced Targeted Initiatives to Broaden Appeal and Expand Customer Base Actions Taken to Reduce Costs and Strengthen Profitability Fourth quarter 2024 highlights: Net revenue from continuing operations of $437.3 million, an increase of 3.9% as compared to Q4 2023 Comparable store sales growth of 2.6% and Adjusted Comparable Store Sales Growth of 1.5% as compared to Q4 2023 Net loss from continuing operations of $(29.4) million, Diluted EPS from continuing operations of $(0.37) Adjusted Operating Income from continuing operations increased to $3.2 million from $(2.7) mill

      2/26/25 6:00:00 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Holdings, Inc. Announces Fourth Quarter and Fiscal 2024 Earnings Release and Conference Call

      National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") will report its fourth quarter and fiscal 2024 financial results before the market opens on February 26, 2025 and will host a conference call at 8:00 a.m. Eastern Time. To pre-register for the conference call and obtain a dial-in number and passcode, please refer to the "Investors" section of the Company's website at www.nationalvision.com/investors. A live audio webcast of the conference call, together with related materials, will be available online in the "Investors" section of the Company's website. A replay of the audio webcast will be available shortly after the broadcast. About National Vision Holdin

      2/12/25 8:00:00 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Holdings, Inc. Reports Third Quarter 2024 Financial Results

      Results Reflect Ongoing Strength in Managed Care with Growth in America's Best as Transformation Initiatives Progress Third quarter 2024 highlights compared to Q3 2023: Net revenue from continuing operations of $451.5 million, an increase of 2.9% Comparable store sales growth of 1.4% and Adjusted Comparable Store Sales Growth of 0.9% Net loss from continuing operations of $(8.4) million, Diluted EPS from continuing operations of $(0.11) Adjusted Operating Income from continuing operations of $14.3 million Adjusted Diluted EPS from continuing operations of $0.12 Reaffirms fiscal 2024 outlook for key metrics, updates capital expenditure expectations National Vision Holdings, In

      11/6/24 6:00:00 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Holdings, Inc. Announces Third Quarter 2024 Earnings Release and Conference Call

      National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") will report its third quarter 2024 financial results before the market opens on Wednesday, November 6, 2024 and will host a conference call at 8:30 a.m. Eastern Time. To pre-register for the conference call and obtain a dial-in number and passcode, please refer to the "Investors" section of the Company's website at www.nationalvision.com/investors. A live audio webcast of the conference call, together with related materials, will be available online in the "Investors" section of the Company's website. A replay of the audio webcast will be available shortly after the broadcast. About National Vision Holdings,

      10/23/24 8:00:00 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Holdings, Inc. Reports Second Quarter 2024 Financial Results

      Announces New Actions to Accelerate Transformation Second quarter 2024 highlights(1) compared to Q2 2023: Net revenue from continuing operations of $451.7 million, an increase of 4.6% Comparable store sales growth of 2.2% and Adjusted Comparable Store Sales Growth of 2.4% Net loss from continuing operations of $(1.0) million, Diluted EPS from continuing operations of $(0.01) Adjusted Operating Income from continuing operations of $14.1 million Adjusted Diluted EPS from continuing operations of $0.15 Discontinued Operations resulted in net revenue of $53.5 million, Net loss, net of tax, of $(2.1) million, Diluted EPS of $(0.03) and Adjusted Diluted EPS of $0.00 Revises

      8/7/24 6:01:00 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Holdings, Inc. Announces Second Quarter 2024 Earnings Release and Conference Call

      National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") will report its second quarter 2024 financial results before the market opens on Wednesday, August 7, 2024 and will host a conference call at 8:30 a.m. Eastern Time. To pre-register for the conference call and obtain a dial-in number and passcode, please refer to the "Investors" section of the Company's website at www.nationalvision.com/investors. A live audio webcast of the conference call, together with related materials, will be available online in the "Investors" section of the Company's website. A replay of the audio webcast will be available shortly after the broadcast. About National Vision Holdings,

      7/24/24 8:00:00 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Holdings, Inc. Reports First Quarter 2024 Financial Results

      First Quarter 2024 Continuing Operations Highlights(1): Net revenue of $542.5 million, an increase of 4.2% from $520.8 million Comparable store sales growth of 1.4% and Adjusted Comparable Store Sales Growth of 0.4% Total Company Net income of $11.7 million Adjusted Operating Income of $35.8 million Diluted EPS of $0.16 and Adjusted Diluted EPS of $0.30 First Quarter 2024 Total Company Highlights(1): Net revenue of $560.9 million, a decrease of (0.3)% from $562.4 million Comparable store sales growth of 2.1% and Adjusted Comparable Store Sales Growth of (0.1)% Adjusted Operating Income of $35.0 million Diluted EPS of $0.15 and Adjusted Diluted EPS of $0.32 C

      5/8/24 6:00:00 AM ET
      $EYE
      Ophthalmic Goods
      Health Care
    • National Vision Holdings, Inc. Announces First Quarter 2024 Earnings Release and Conference Call

      National Vision Holdings, Inc. (NASDAQ:EYE) ("National Vision" or the "Company") will report its first quarter 2024 financial results before the market opens on Wednesday, May 8, 2024. The Company will host a conference call to discuss these results on Wednesday, May 8, 2024, at 8:30 a.m. Eastern Time. To pre-register for the conference call and obtain a dial-in number and passcode, please refer to the "Investors" section of the Company's website at www.nationalvision.com/investors. A live audio webcast of the conference call, together with related materials, will be available online in the "Investors" section of the Company's website. A replay of the audio webcast will be available short

      4/24/24 8:00:00 AM ET
      $EYE
      Ophthalmic Goods
      Health Care